
A brief thread on our recently published work on CXCL9 as a diagnostic biomarker for acute tubulointerstitial nephritis (AIN) jci.org/articles/view/168950 @jclinicalinvest @YaleMed @YaleIMed @YaleNephrology @KidneydrChirag @fperrywilson

Chief of Nephrology, Rutgers RWJ medical school

A brief thread on our recently published work on CXCL9 as a diagnostic biomarker for acute tubulointerstitial nephritis (AIN) jci.org/articles/view/168950 @jclinicalinvest @YaleMed @YaleIMed @YaleNephrology @KidneydrChirag @fperrywilson

1 in 5 patients develops acute kidney injury (AKI) within the first year of starting cancer immunotherapy. Researchers are investigating whether checkpoint inhibitors are causing acute interstitial nephritis. Read more in the Q&A with @dmoledina. medicine.yale.edu/internal-m…

The value of KPMP is starting…congrats…great work. mdcalc.com/calc/10550/acute-…

New @hopkinsneph study uses new electronic diagnostic model as an alternative to kidney biopsies to predict AIN. @KidneydrChirag bit.ly/4hKaEXK

This important advance was greatly enabled by superstars who are developing kidney biopsy registries at their institutions @dmoledina @StevenMenez
New @hopkinsneph study uses new electronic diagnostic model as an alternative to kidney biopsies to predict AIN. @KidneydrChirag bit.ly/4hKaEXK

I hope people will use the AIN calculator to differentiate AIN from ATN on AKI consults. Let us know if you have questions or additional suggestions. @dmoledina
The value of KPMP is starting…congrats…great work. mdcalc.com/calc/10550/acute-…

📸 Tiffany B from @lloydcantley1 presenting her IMC work @KPMProject 📸 Sagar S and @KidneydrChirag presenting a poster together @dmoledina @fperrywilson 📸 Bhavya B focused on her work in @lloydcantley1 lab 📸 More HRS data from @jmbnephdoc So much to see! #KidneyWk

Dr. Leyuan Xu presenting the Immune Landscape of AKI in 6B at @ASNKidney #KidneyWk now! Excellent talk and excellent summary slide! @lloydcantley1 @dmoledina @PKDSteve @KidneydrChirag

📸 @meganlebaker giving her first oral presentation at @ASNKidney #KidneyWk this afternoon, on her work characterizing immune-tubulointerstitial interactions in AIN and ATI! @lloydcantley1 @dmoledina

New in @JASN_News : external validation of a diagnostic model for predicting biopsy-proven AIN increased AUC of clinicians' prebiopsy suspicion for AIN by 0.10 to 0.77! Awesome tool! @dmoledina @Nephronette @fperrywilson @KidneydrChirag @YaleIMed journals.lww.com/jasn/abstra…

Accurate diagnosis of acute tubulointerstitial nephritis (AIN) often requires a kidney biopsy. This study found that an AIN diagnostic model retained discrimination in two validation cohorts but needed recalibration to account for local AIN prevalence. bit.ly/JASN0556 @dmoledina @fperrywilson @kidneydrchirag @Nephronette @oconnkyle @StevenMenez

A new #clinicaltrial led by @YaleIMed's @dmoledina seeks to use biomarkers to detect when kidney injury results from #immunotherapy complications, reducing treatment interruptions for patients with #cancer. Learn more in a YSM Q&A: brnw.ch/21wOtYY

Dr. Dennis Moledina @dmoledina discusses his research into identifying and validating #biomarkers for the diagnosis of acute interstitial #nephritis. Watch his #GrandRounds talk now youtu.be/Bgk9c7VCZmc. #kidneycancer @SmilowCancer @YaleMed @YNHH

Dr Erin Barreto @erin_barreto - medication management in AKI: moving beyond “medications reviewed” #NKFClinicals

Multidisciplinary Care of Patients Hospitalized with AKI - @javo_neyra kicking off the session #NKFClinicals

#NKFClinicals interprofessional care of patients with AKI: it takes a village @JeffNeph @javo_neyra @erin_barreto